| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/16/2002 | US6420548 Method for regulating transcription of foreign genes |
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420534 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 07/16/2002 | US6420529 Chimeric protein with cytoplasmic kinase domain of yeast protein |
| 07/16/2002 | US6420524 Gain of function mutations in ATP-dependent transposition proteins |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420338 Hepatitis b virus (hbv); hepatocellular carcinoma |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420177 Method for strain improvement of the erythromycin-producing bacterium |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420163 Genetically engineered cell for use in prevention and treatment of bacterial, viral, fungal and parasitic infections |
| 07/16/2002 | US6420162 Nucleic acids encoding hskif16a, a kinesin motor protein |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420159 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use |
| 07/16/2002 | US6420158 Nuclelotide coding enzymatic polypeptide for use in bioremediation of fossil fuels |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420156 Purified proteolytic enzyme and method of purification |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420154 Mammalian adhesion protease peptides |
| 07/16/2002 | US6420153 Nucleotide sequences coding enzymatic polypeptides for use in the diagnosis, treatment and prevention of blood disorders and leukemias |
| 07/16/2002 | US6420152 Bacterial enzymatic polypeptide for use in detection of infection |
| 07/16/2002 | US6420151 Used in fermentative preparation of l-amino acids, in particular l-lysine and l-threonine |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420149 Polypeptides |
| 07/16/2002 | US6420148 Fixation of preferential polypeptides; obtain protein, incubate with preferential oxidase, evaluate fixed protein |
| 07/16/2002 | US6420142 Method for enzymatic splitting of rutinosides |
| 07/16/2002 | US6420131 Monitoring prefrential enzymatic activity; obtain sample of enzymatic polypeptide, incubate with modulator, evaluate the modulator ability to inhibit enzymatic polypeptide |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | CA2366135A1 New genes containing a dna sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2254647C Chimeric serine proteases |
| 07/16/2002 | CA2193094C The cytoplasmic inhibition of gene expression |
| 07/16/2002 | CA2124580C Method for selecting recombinant microorganisms containing at their surface at least one molecule having enzymatic activity |
| 07/16/2002 | CA2097200C Protein tyrosine kinase |
| 07/16/2002 | CA2089498C Soluble aldc derivative and use thereof |
| 07/11/2002 | WO2002054066A2 Non-apoptotic forms of cell death and methods of modulation |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053772A1 Novel biosensor system |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053756A2 Regulation of human glucosamine-6-phosphate deaminase |
| 07/11/2002 | WO2002053755A2 Regulation of human otu-like cysteine protease |
| 07/11/2002 | WO2002053754A2 Human protease and polynucleotides encoding the same |
| 07/11/2002 | WO2002053753A2 Novel human lipase and polynucleotides encoding the same |
| 07/11/2002 | WO2002053752A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | WO2002053751A1 Polypeptides, polynucleotides, recombinant nucleic acids, recombinants, and process for producing prenyl alcohol |
| 07/11/2002 | WO2002053750A2 Inactivation of the polyphosphate kinase gene for microbial overproduction of antibiotics or enzymes |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053748A1 Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase |
| 07/11/2002 | WO2002053747A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053746A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053745A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |
| 07/11/2002 | WO2002053722A1 Ginsenoside glycosidase which hydrolyzes ginsenoside glycosyl and the use thereof |
| 07/11/2002 | WO2002053721A1 Low-lipoxygenase 1 barley |
| 07/11/2002 | WO2002053720A1 Low-lipoxygenase 1 barley |
| 07/11/2002 | WO2002053719A2 Cytoskeleton-associated proteins |
| 07/11/2002 | WO2002053718A2 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053716A2 Regulation of human ornithine decarboxylase |
| 07/11/2002 | WO2002053715A2 Nucleoside diphosphate hydrolase |
| 07/11/2002 | WO2002053714A2 Regulation of human phosphatidylinositol-4-phosphate 5-kinase |
| 07/11/2002 | WO2002053713A2 Cloning of a human sulfotransferase |
| 07/11/2002 | WO2002053704A2 Protein-protein interactions |
| 07/11/2002 | WO2002053703A2 Aav2 vectors and methods |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053590A1 A novel fibrinolytic enzyme the polynucleotide encoding said polypeptide and the use thereof |
| 07/11/2002 | WO2002053582A2 Process for producing peptides by using in vitrotranscription/translation system |
| 07/11/2002 | WO2002053579A2 Haplotypes of the fmo2 gene |
| 07/11/2002 | WO2002053569A1 Method of assaying lysophospholipase d activity |
| 07/11/2002 | WO2002053170A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 07/11/2002 | WO2002053103A2 Pharmacological targeting of mrna cap formation for treatment of parasitic infections |
| 07/11/2002 | WO2002034923A8 Monocotyledon plant cells and plants which synthesise modified starch |
| 07/11/2002 | WO2002034901A3 Protein kinase |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002030970A3 Human histone deacetylase gene |
| 07/11/2002 | WO2002026955A3 Human proteases and polynucleotides encoding the same |
| 07/11/2002 | WO2002022829A3 Nucleotide sequences which code for the ppsa gene |
| 07/11/2002 | WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 07/11/2002 | WO2002020728A3 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2002 | WO2002009646A3 Plant derived antioxidants |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2002006454A3 Regulation of human carboxylesterase-like enzyme |
| 07/11/2002 | WO2002004610A3 Regulation of human dipeptidyl-peptidase iv-like enzyme |
| 07/11/2002 | WO2002000862A3 32447, a novel human acyltransferase and uses thereof |
| 07/11/2002 | WO2002000854A3 Regulation of human phosphodiesterase-like enzyme |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001085970A3 Resistance to acetohydroxyacid synthase-inhibiting herbicides |
| 07/11/2002 | WO2001083781A3 14094, a novel human trypsin family member and uses thereof |
| 07/11/2002 | WO2001083727A3 Fluid bed process for the production of enzyme granules |
| 07/11/2002 | WO2001050847A3 Reca / rad51 recombinase-mediated production of recombinant organisms |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044478A9 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001012802A9 Random mutagenesis and amplification of nucleic acid |
| 07/11/2002 | WO2001010896A3 Factor x analog with an improved ability to be activated |